MetLife Investment Management’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $190K | Sell |
3,569
-2,846
| -44% | -$151K | ﹤0.01% | 2228 |
|
|
2025
Q1 | $278K | Buy |
6,415
+35
| +0.5% | +$1.52K | ﹤0.01% | 2018 |
|
|
2024
Q4 | $358K | Sell |
6,380
-95
| -1% | -$5.34K | ﹤0.01% | 1979 |
|
|
2024
Q3 | $441K | Sell |
6,475
-133
| -2% | -$9.06K | ﹤0.01% | 1847 |
|
|
2024
Q2 | $279K | Buy |
6,608
+566
| +9% | +$23.9K | ﹤0.01% | 2042 |
|
|
2024
Q1 | $417K | Buy |
6,042
+17
| +0.3% | +$1.17K | ﹤0.01% | 1779 |
|
|
2023
Q4 | $446K | Sell |
6,025
-95
| -2% | -$7.03K | ﹤0.01% | 1757 |
|
|
2023
Q3 | $418K | Buy |
6,120
+5
| +0.1% | +$341 | ﹤0.01% | 1743 |
|
|
2023
Q2 | $574K | Buy |
6,115
+1,233
| +25% | +$116K | ﹤0.01% | 1602 |
|
|
2023
Q1 | $331K | Buy |
4,882
+11
| +0.2% | +$746 | ﹤0.01% | 1898 |
|
|
2022
Q4 | $241K | Sell |
4,871
-36
| -0.7% | -$1.78K | ﹤0.01% | 2131 |
|
|
2022
Q3 | $159K | Sell |
4,907
-70
| -1% | -$2.27K | ﹤0.01% | 2434 |
|
|
2022
Q2 | $196K | Sell |
4,977
-5,629
| -53% | -$222K | ﹤0.01% | 2331 |
|
|
2022
Q1 | $742K | Buy |
+10,606
| New | +$742K | ﹤0.01% | 1523 |
|
|
2019
Q2 | – | Sell |
-164
| Closed | -$14.2K | – | 2484 |
|
|
2019
Q1 | $14.2K | Buy |
164
+1
| +0.6% | +$87 | ﹤0.01% | 2360 |
|
|
2018
Q4 | $10.3K | Sell |
163
-2
| -1% | -$126 | ﹤0.01% | 2373 |
|
|
2018
Q3 | $13K | Buy |
+165
| New | +$13K | ﹤0.01% | 2413 |
|
|
2018
Q2 | – | Sell |
-52,309
| Closed | -$2.11M | – | 2187 |
|
|
2018
Q1 | $2.11M | Sell |
52,309
-2,023
| -4% | -$81.6K | 0.02% | 763 |
|
|
2017
Q4 | $2.86M | Buy |
+54,332
| New | +$2.86M | 0.03% | 663 |
|